6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
ID: 36E79725R0035Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/17a9e124e0384359aebac1cc0302787d/view
Timeline
  1. 1
    Posted Apr 10, 2025, 12:00 AM UTC
  2. 2
    Updated Apr 10, 2025, 12:00 AM UTC
  3. 3
    Due May 13, 2025, 7:30 PM UTC
Description

The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg Tablets, which will serve various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract aims to ensure an uninterrupted supply of this essential medication for a period of one year, with options for four additional one-year terms, emphasizing the VA's commitment to maintaining critical pharmaceutical supplies. The estimated annual requirement is approximately 91,583 bottles, and interested offerors must ensure their product has a unique National Drug Code (NDC) and complies with specific packaging requirements, including safety caps. The solicitation is expected to be issued electronically on or around April 26, 2025, with a response deadline of May 13, 2025; inquiries can be directed to Deb Fassl at Deborah.Fassl@va.gov.

Point(s) of Contact
Deb FasslContract Specialist
(708) 786-5894
Deborah.Fassl@va.gov
Files
Title
Posted
36E79725R0035_1.docx
Apr 10, 2025, 1:05 PM UTC
The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg Tablets, which will serve the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The solicitation number is 36E79725R0035, with a response deadline of May 13, 2025. The contract will provide an uninterrupted supply of the medication for a year, with options for four additional one-year terms. Offerors must ensure their product has a unique National Drug Code (NDC) and that proper packaging, including safety caps, is provided. The solicitation will be issued electronically on or around April 26, 2025, and all prospective bidders must regularly check SAM.gov for updates, as no paper copies will be available. The estimated annual usage is 91,583 bottles of the specified tablets. The contact for inquiries is Deb Fassl, whose email is provided. This procurement underscores the VA's commitment to maintaining pharmaceutical supplies for critical health programs.
Lifecycle
Title
Type
6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
Currently viewing
Presolicitation
Similar Opportunities
6505--Topiramate Tablets (VA-25-00047941)
Buyer not available
The Department of Veterans Affairs (VA) is seeking proposals for the supply of Topiramate Tablets, a pharmaceutical product essential for meeting the medication needs of VA facilities and other government agencies. The procurement aims to establish a contract through the VA Pharmaceutical Prime Vendor Program, requiring offerors to submit detailed proposals that include pricing for a base year and four option years, with a 0.5% Cost Recovery Fee incorporated. Compliance with the Drug Supply Chain Security Act (DSCSA), adherence to specific packaging requirements, and maintenance of current Good Manufacturing Practices (cGMP) verified by the FDA are critical components of the contract. Interested parties should contact Contract Specialist Billy Fong at Billy.Fong@va.gov for further details regarding the solicitation.
NALTREXONE -50MG -100CT - Multiple CMOPs - 770-25-3-801-0426
Buyer not available
The Department of Veterans Affairs is preparing to solicit proposals for the procurement of 50mg Naltrexone tablets, packaged in 100-count bottles, for delivery to multiple Consolidated Mail Outpatient Pharmacies (CMOP) across the United States. This presolicitation notice (RFQ: 36C77025Q0114) indicates a commitment to full and open competition, allowing all responsible vendors to submit quotations by the response deadline of May 6, 2025, at 4 PM Central Time. The procurement of these pharmaceuticals is crucial for meeting the ongoing healthcare needs of veterans, ensuring compliance with regulatory standards such as the Drug Supply Chain Security Act. Interested vendors must direct their responses to Contract Specialist Jennifer Knight via email at jennifer.knight@va.gov, with the estimated issue date for the solicitation set for April 29, 2025.
6505--Metformin IR Tablets
Buyer not available
The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Metformin HCL IR Tablets as part of its pharmaceutical prime vendor programs, which also serve the Department of Defense (DoD). Offerors are required to submit pricing for various bottle sizes and quantities, ensure compliance with FDA regulations, and adhere to the Drug Supply Chain Security Act (DSCSA), including providing a unique National Drug Code (NDC) for each product. This procurement is crucial for maintaining a reliable source of pharmaceutical products, ensuring consistent availability and pricing while meeting federal regulatory standards. Interested parties should contact Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov for further details, and proposals must be submitted in accordance with the outlined requirements within the specified timeframe.
6505--Perphenazine Tablets (VA-25-00037353)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to ensure a reliable supply of this pharmaceutical product for both the Department of Veterans Affairs and the Department of Defense, with a focus on service-disabled veteran-owned, women-owned, and HUBZone small businesses. The procurement process will adhere to the Drug Supply Chain Security Act and require compliance with FDA regulations, including Good Manufacturing Practices. Interested offerors must submit their proposals by May 1, 2025, at 2:30 PM CDT, and can direct inquiries to Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov.
6505--Buspirone RFP
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Buspirone HCL, a pharmaceutical product essential for the healthcare services provided to veterans. The procurement process requires vendors to submit pricing for multiple line items covering a base year and four option years, ensuring compliance with the Drug Supply Chain Security Act and FDA Good Manufacturing Practices. This contract aims to maintain a reliable supply chain for federal healthcare providers, including the VA, Department of Defense, and Indian Health Service, while securing volume-based pricing for the necessary pharmaceuticals. Interested vendors must submit their offers by May 8, 2025, at 2:30 PM CT, and can direct inquiries to Contract Specialist Amber Zavala at amber.zavala@va.gov.
6505--Ranolazine Sustained Action (SA) Tablets
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Ranolazine Sustained Action Tablets, a pharmaceutical product essential for veteran healthcare. Bidders are required to submit pricing for a base year and four option years, along with compliance documentation including National Drug Code (NDC) numbers and adherence to packaging specifications as mandated by the Drug Supply Chain Security Act. This procurement underscores the government's commitment to ensuring a reliable supply of quality medications while adhering to federal standards, including Good Manufacturing Practices (cGMP). Interested parties should contact Contract Specialist Deborah S. Fassl at Deborah.Fassl@va.gov for further details regarding submission requirements and deadlines.
6505--Carvedilol Tablets (VA-25-00048048)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Carvedilol Tablets under solicitation number 36E79725R0028, with an amendment extending the submission deadline to May 1, 2025, at 2:30 PM Central Daylight Time. Offerors are required to provide pricing for various types of Carvedilol Tablets, submit unique National Drug Code (NDC) numbers, and comply with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards. This procurement is crucial for ensuring a reliable supply of pharmaceuticals to enhance healthcare services for veterans and active duty military personnel. Interested contractors should direct their proposals to the specified VA email addresses and acknowledge receipt of the amendment to remain eligible for consideration.
6505--Acyclovir Capsules (VA-25-00048078)
Buyer not available
The Department of Veterans Affairs is seeking proposals for the procurement of Acyclovir Capsules, specifically 200MG capsules in two packaging sizes, to support the healthcare needs of veterans. The solicitation includes two line items: Line Item 1 requires 3,256 bottles of 100 capsules per bottle, and Line Item 2 requests 15,475 bottles of 500 capsules per bottle, with the same quantities needed for the base year and each of the four option years. This procurement is crucial for ensuring a reliable supply of essential pharmaceuticals for veterans, emphasizing the importance of compliance and competition within the pharmaceutical supply chain. Interested suppliers must submit their pricing proposals by May 1, 2025, and can contact Contracting Officer Andrew Cazares at andrew.cazaeres@va.gov or (708) 786-4990 for further details.
6505--Loperamide Capsules (VA-25-00032225)
Buyer not available
The Department of Veterans Affairs (VA) is seeking proposals for the supply of Loperamide Hydrochloride (HCL) 2mg capsules, as outlined in solicitation number 36E79725R0025. Offerors must provide pricing for a base year and four additional one-year options, including a 0.5% Cost Recovery Fee and unique 11-digit National Drug Codes (NDC) for their products, while adhering to regulatory standards such as the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This procurement is crucial for ensuring the availability of essential pharmaceutical products to VA facilities and other government health service providers. The deadline for proposal submissions has been extended to April 30, 2025, at 2:30 PM Central Time, and interested parties should contact Contract Specialist Nicholas I McGregor at Nicholas.McGregor@va.gov for further information.
National CMOP F0354 FENOFIBRATE (770-25-3-801-0369)
Buyer not available
The Department of Veterans Affairs is preparing to solicit bids for the procurement of FENOFIBRATE 48MG tablets, intended for delivery to various Consolidated Mail Outpatient Pharmacy (CMOP) locations. This presolicitation notice outlines the requirement for small businesses to provide the specified pharmaceutical product, emphasizing compliance with federal regulations such as the Drug Supply Chain Security Act (DSCSA). The procurement is crucial for maintaining a reliable supply chain of essential medications to support the healthcare needs of veterans. Interested parties must submit their quotes electronically by May 2, 2025, at 4 PM Central Time, and are encouraged to contact Jennifer L Knight at jennifer.knight@va.gov or 913-684-0162 for further information.